首页|期刊导航|临床传统医学和药理学(英文)|Dillenia indica L.果实提取物对链脲佐菌素诱导的糖尿病相关血脂异常大鼠模型肝脏Cyp7a1基因表达的影响

Dillenia indica L.果实提取物对链脲佐菌素诱导的糖尿病相关血脂异常大鼠模型肝脏Cyp7a1基因表达的影响OA

Effects of Dillenia indica L.fruit extract on hepatic Cyp7a1 gene expression in a rat model of streptozotocin-induced diabetes-associated dyslipidemia

中文摘要英文摘要

背景:长期以来的文献记载表明,Dillenia indica果实具有包括抗糖尿病活性与抗血脂异常活性等多种健康功效.目的:探讨D.indica果实80%甲醇提取物(DiME)是否通过调控肝脏Cyp7a1基因表达发挥降血糖与调血脂作用.方法:采用定性检测与气相色谱-串联质谱(GC-MS/MS)分析DiME的植物化学组成.对出生48小时的幼鼠单次腹腔注射链脲佐菌素(90mg/kg)诱导糖尿病;3月龄后经口服葡萄糖耐量试验(OGTT)验证,确认18只成年大鼠成功构建2型糖尿病(T2DM)模型.随后给予含2%胆固醇+1%胆酸的高胆固醇饲料饲喂4周,诱导血脂异常.将大鼠随机分为4组(每组6只),连续给药28天.氟烷麻醉下采集血液样本,通过检测空腹血糖(FSG)、胰岛素、稳态模型评估指数(HOMA-B胰岛β细胞功能、HOMA-S胰岛素敏感性、HOMA-IR胰岛素抵抗)、血脂谱(总胆固醇TC、甘油三酯TG、低密度脂蛋白胆固醇LDL-C、高密度脂蛋白胆固醇HDL-C)及肝酶(天冬氨酸转氨酶AST、丙氨酸转氨酶ALT)评价治疗效果.机制研究包括血清超氧化物歧化酶(SOD)活性检测、胰腺组织病理学检查、肝脏Cyp7a1基因表达的半定量逆转录-聚合酶链反应(RT-PCR)分析,以及计算机分子对接研究.结果:DiME富含萜类、酚类与脂肪酸类成分.体内实验显示,DiME干预可显著降低空腹血糖(P<0.01),改善血脂谱—降低血清TG、TC、LDL-C水平,升高HDL-C水平(P<0.05);同时血清胰岛素水平升高93%(P<0.001),HOMA-B指数与HOMA-S指数显著改善.组织学结果证实DiME可维持胰岛结构完整性.此外,DiME可提升血清SOD活性以改善氧化应激,并降低升高的血清AST、ALT水平,发挥肝保护作用.机制层面,DiME干预可使肝脏Cyp7a1基因表达上调约3倍.结论:DiME通过双重机制发挥治疗作用:一方面促进胰腺胰岛素分泌、改善外周胰岛素敏感性;另一方面上调肝脏Cyp7a1表达,促进胆固醇分解代谢.

Background:Dillenia indica fruit has long been documented to exert multiple health benefits,including antidiabetic and antidyslipidemic activities. Objective:To investigate whether modulation of hepatic Cyp7a1 gene expression mediates the antidiabetic and antidyslipidemic effects of an 80%methanolic extract of D.indica fruit(DiME). Methods:Phytochemical profiling of DiME was performed using qualitative assays and gas chromatography-tandem mass spectrometry(GC-MS/MS).Diabetes was induced in 48-hour-old rat pups via a single intraperi-toneal injection of streptozotocin(90 mg/kg).After 3 months,18 adult rats were confirmed as type 2 diabetes mellitus(T2DM)models using the oral glucose tolerance test(OGTT).Dyslipidemia was subsequently induced by feeding a high-cholesterol diet supplemented with 2%cholesterol and 1%cholic acid for 4 weeks.The rats were then randomly divided into four groups(n=6 per group)and received respective treatments for 28 con-secutive days.Blood samples were collected under halothane anesthesia.Therapeutic efficacy was evaluated by measuring fasting serum glucose(FSG),insulin,homeostatic model assessment(HOMA)indices(HOMA-B,HOMA-S,HOMA-IR),lipid profiles(total cholesterol(TC),triglyceride(TG),low-density lipoprotein(LDL)choles-terol,high-density lipoprotein(HDL)cholesterol),and liver enzymes(aspartate aminotransferase(AST),alanine aminotransferase(ALT)).Mechanistic studies included measurement of serum superoxide dismutase(SOD)activ-ity,pancreatic histopathological examination,semi-quantitative reverse transcription-polymerase chain reaction(RT-PCR)analysis of hepatic Cyp7a1 gene expression,and in silico molecular docking. Results:DiME was rich in terpenoids,phenols,and fatty acids.In vivo,DiME treatment significantly reduced FSG(P<0.01)and markedly improved lipid profiles by decreasing serum TG,TC,and LDL cholesterol,while increas-ing HDL cholesterol(P<0.05).This was accompanied by a 93%elevation in serum insulin levels(P<0.001)and significant improvements in pancreatic β-cell function(HOMA-B)and insulin sensitivity(HOMA-S).Histo-logical analysis confirmed preservation of pancreatic islet integrity.DiME also ameliorated oxidative stress by increasing serum SOD activity and exerted hepatoprotective effects by reducing elevated serum AST and ALT levels.Mechanistically,DiME treatment induced an approximately 3-fold upregulation of hepatic Cyp7a1 gene expression. Conclusion:These findings indicate that DiME exerts its therapeutic effects via a dual mechanism by enhancing pancreatic insulin secretion and peripheral insulin sensitivity,and upregulating hepatic Cyp7a1 expression to promote cholesterol catabolism.

Md Mahedi Hassan Tusher;Begum Rokeya;Md Asrafuzzaman;Md Hafizur Rahman;Sajib Halder;Nayem Sarker;Fatima Anjum Faruquee;Maliha Tabassum Rashid;Marzan Islam Lubaba;Abdullah Tayeb Fahim

Department of Pharmacology,Bangladesh University of Health Sciences(BUHS),125/1,Darus Salam,Mirpur-1,Dhaka 1216,Bangladesh||Asian Network of Research on Antidiabetic Plants(ANRAP),Bangladesh University of Health Sciences(BUHS),125/1,Darus Salam,Mirpur-1,Dhaka 1216,BangladeshDepartment of Pharmacology,Bangladesh University of Health Sciences(BUHS),125/1,Darus Salam,Mirpur-1,Dhaka 1216,Bangladesh||Asian Network of Research on Antidiabetic Plants(ANRAP),Bangladesh University of Health Sciences(BUHS),125/1,Darus Salam,Mirpur-1,Dhaka 1216,BangladeshAsian Network of Research on Antidiabetic Plants(ANRAP),Bangladesh University of Health Sciences(BUHS),125/1,Darus Salam,Mirpur-1,Dhaka 1216,BangladeshAsian Network of Research on Antidiabetic Plants(ANRAP),Bangladesh University of Health Sciences(BUHS),125/1,Darus Salam,Mirpur-1,Dhaka 1216,BangladeshAsian Network of Research on Antidiabetic Plants(ANRAP),Bangladesh University of Health Sciences(BUHS),125/1,Darus Salam,Mirpur-1,Dhaka 1216,BangladeshAsian Network of Research on Antidiabetic Plants(ANRAP),Bangladesh University of Health Sciences(BUHS),125/1,Darus Salam,Mirpur-1,Dhaka 1216,BangladeshDepartment of Pharmacology,Bangladesh University of Health Sciences(BUHS),125/1,Darus Salam,Mirpur-1,Dhaka 1216,BangladeshAsian Network of Research on Antidiabetic Plants(ANRAP),Bangladesh University of Health Sciences(BUHS),125/1,Darus Salam,Mirpur-1,Dhaka 1216,BangladeshAsian Network of Research on Antidiabetic Plants(ANRAP),Bangladesh University of Health Sciences(BUHS),125/1,Darus Salam,Mirpur-1,Dhaka 1216,BangladeshAsian Network of Research on Antidiabetic Plants(ANRAP),Bangladesh University of Health Sciences(BUHS),125/1,Darus Salam,Mirpur-1,Dhaka 1216,Bangladesh

Dillenia indica血脂异常胆固醇7α-羟化酶2型糖尿病气相色谱-串联质谱分子对接

Dillenia indica L.Dyslipidemia,Cyp7a1Type 2 diabetes mellitusGC-MS/MS,Molecular docking

《临床传统医学和药理学(英文)》 2026 (2)

88-100,13

This work was supported by the Ministry of Science and Technology[grant number #39.009.006.01.00.049.2013-14/MEDES-38/219]In-ternational Program in the Chemical Sciences,Uppsala University[grant number ISPdrn2022/1:6].

10.1016/j.ctmp.2026.200289

评论